Actinium Pharmaceuticals
ATNM
#9861
Rank
S$57.31 M
Marketcap
S$1.84
Share price
-0.70%
Change (1 day)
5.38%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2025 (TTM): -S$58.28 Million

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -S$54.5 Million, an increase over its 2023 earnings that were of -S$67.18 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$58.28 Million6.93%
2024 -S$54.5 Million-18.87%
2023 -S$67.18 Million52.24%
2022 -S$44.13 Million36.61%
2021 -S$32.31 Million11.48%
2020 -S$28.98 Million1.46%
2019 -S$28.56 Million-7.37%
2018 -S$30.83 Million-11.46%
2017 -S$34.82 Million10.67%
2016 -S$31.47 Million15.7%
2015 -S$27.2 Million-14.86%
2014 -S$31.95 Million129.19%
2013 -S$13.94 Million-8.55%
2012 -S$15.24 Million
2010 S$0.01 M-152.15%
2009 -S$0.03 Million-39.8%
2008 -S$0.04 Million120.29%
2007 -S$0.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Genocea Biosciences
GNCA
-S$48.13 Million-15.95%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$0.87 B-1,635.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
S$6.44 M-111.26%๐Ÿ‡บ๐Ÿ‡ธ USA